XML 27 R15.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' Equity
3 Months Ended
Mar. 31, 2016
Stockholders' Equity [Abstract]  
Stockholders' Equity

10. Stockholders’ Equity 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the prior rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. Since the Company’s inception, no dividends have been declared or paid.

Controlled Equity Offering

The Company entered into a Controlled Equity OfferingSM sales agreement (the “Sales Agreement”) in May 2014, as amended on March 26, 2015, with Cantor Fitzgerald & Co. (“Cantor”), as agent and/or principal, pursuant to which the Company could issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $18.0 million. The Company will pay Cantor a commission of 3.0% of the gross proceeds from any common stock sold through the Sales Agreement.

There were no proceeds from the Controlled Equity Offering during the three months ended March 31, 2016.  As of March 31, 2016, $13.8 million of common stock remained available to be sold under this facility, subject to certain conditions as specified in the Sales Agreement.

Offerings of Common Stock 

On October 8, 2015 the Company announced the results of its previously announced offering of transferable subscription warrants (the “Warrants Offering) to holders of record of the Company’s common stock. Pursuant to the Warrants Offering, subscription warrants to purchase 267,256 shares of common stock were exercised, resulting in gross proceeds to the Company of $293,982.

Stock Award Plans

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation.  In August 2012, the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012. 

On June 5, 2013 and on June 10, 2014, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Each of these amendments increased the number of shares authorized for issuance under the Plan by one million shares. At March 31, 2016, the Company had 46,051 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

At March  31, 2016, the total compensation cost related to options, stock appreciation rights and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $2.3 million, net of estimated forfeitures of approximately $0.7 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in estimated forfeitures and anticipated vesting periods. 

A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2016 is as follows:





 

 

 

 

 



Number of Options/SARs

 

Range of Exercise Price

 

Weighted Average Exercise Price per Share



 

 

 

 

 

Outstanding, December 31, 2015

706,494 

 

$1.45 - $116.40

 

$9.34 

Granted

 -

 

 -

 

 -

Exercised

 -

 

 -

 

 -

Forfeited

(11,377)

 

$1.74 - $36.20

 

$9.98 

Outstanding, March 31, 2016

695,117 

 

$1.45 - $116.40

 

$9.32 





 



 

 

 









A summary of the restricted stock unit activity for the three month period ended March  31, 2016 is as follows:





 

 

 



Number of Restricted Stock Units

 

Weighted Average Grant Date Fair Value per Unit



 

 

 

Outstanding, December 31, 2015

752,008 

 

$2.63 

Granted

700,600 

 

$0.78 

Vested

(175,100)

 

$3.00 

Forfeited

(6,232)

 

$2.73 

Outstanding, March 31, 2016

1,271,276 

 

$1.56